| Authors | Ter Heegde, F., Jones, R.C., Jackson, T.R., De Pascale, C., Locke, I.C., Board, T.N., Richardson, S.M., Townsend, P.A. and Lawrence, K.M. |
|---|
| Abstract | Purpose: Traumatic injury to the joint commonly develops into an accelerated form of osteoarthritis. This post traumatic osteoarthritis (PTO) is frequently associated with sports injury and represents a significant proportion of patients presenting with osteoarthritis. Currently, there are no treatments other than analgesics and joint replacement surgery. The development of PTO, although multifactorial, is closely associated with chondrocyte cell death. We have recently found that the peptide Urocortin (Ucn1), its receptor (CRF-R1) and regulatory binding protein (CRF-BP) are expressed by chondrocytes, thus constituting an intact and functional Ucn1 signalling system. Furthermore, in a cartilage explant model of acute impact injury, we found that Ucn1 potently protects chondrocytes from death when applied both pre- and post-impact. These finding suggests a potential role for Ucn1 in preventing cartilage tissue damage in PTO and as a novel therapeutic. Studies investigating the effects of mechanical loading on articular cartilage have been performed in vitro or with ex vivo cartilage explants. However, these are not ideal as crucial interactions between cells and their environment are lost, and reliable pathology may be compromised by dissection and culture. The most common in vivo models that simulate mechanical injury involve surgical joint destabilisation; these are severely disadvantaged by the need for surgery, increasing infection risk, trauma, and effects on joint cell metabolism. There is, therefore, a need for a nonsurgical model allowing for adjustment of specific components of the applied load, including its magnitude, frequency,and loading cycle shape, which can reflect the variable loads encountered throughout life and importantly display a developmental pathology similar to PTO in humans. Methods: Here we used a non-invasive controlled axial loading of the mouse tibia model, enabling loading through normal points of articulation and precisely controlled mechanical loading regimens. In order to induce osteoarthritis, the right knee of 12 week old male C57/bl6 mice was loaded at 9N (pathological load). A single loading episode consisted of 40 loading cycles with a trapezoidal wave form in which 9N was applied for 0.05sec with a rise and fall time of 0.025sec followed by a 9.9sec rest time at a holding load of 2N. This loading episode was repeated 3 times per week for two weeks after which animals were kept for 6 more weeks with no loading before sacrifice (Schematic1). The control group used consisted of mice receiving a 2N holding load without any applied load. At week 8, knee joints exposed to both loads were fixed, decalcified, embedded in paraffin and sectioned coronally at 6mm. These were then subjected to immunohistochemistry using antibodies specific for Ucn1 itself, CRF-R1 and CRF-BP, and visualised using an HRP conjugated secondary antibody. Results: It has been previously demonstrated that the loading regimen presented in Schematic1 causes significant development of PTO when compared to a holding load alone. We found positive immunostaining in cartilage tissue with all three antibodies for the Ucn system members. Expression levels of CRF-R1 and CRF-BP did not alter with load severity. However, we found that expression of Ucn1 itself was markedly reduced in the cartilage of mice exposed to a 9N pathological load when compared to the holding load of 2N. Conclusions: We have found expression of Ucn system members in articular cartilage at the protein level in vivo, including the ligand itself, its receptor and regulatory binding protein, suggesting an intact signalling pathway and regulatory system.There was a profound decrease in Ucn1 protein expression in the cartilage of joints exposed to a loading regimen which develops into PTO. This finding suggests a post-injury loss of Ucn1 signalling, caused by a decrease in Ucn1 expression, which may be responsible for the initiation or progression of PTO. |
|---|